Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anti-MAGEA8 antibody (1-80 aa) (STJ191704) | Login | Anti-MAGEA8 antibody (1-80 aa) (STJ191704) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGEA11 antibody (30-110 aa) (STJ191705) | Login | Anti-MAGEA11 antibody (30-110 aa) (STJ191705) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGEA12 antibody (40-120 aa) (STJ191706) | Login | Anti-MAGEA12 antibody (40-120 aa) (STJ191706) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGEB2 antibody (30-110 aa) (STJ191707) | Login | Anti-MAGEB2 antibody (30-110 aa) (STJ191707) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGEB3 antibody (1-80 aa) (STJ191708) | Login | Anti-MAGEB3 antibody (1-80 aa) (STJ191708) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGEB6 antibody (160-240 aa) (STJ191709) | Login | Anti-MAGEB6 antibody (160-240 aa) (STJ191709) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGEB10 antibody (40-120 aa) (STJ191710) | Login | Anti-MAGEB10 antibody (40-120 aa) (STJ191710) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGEB18 antibody (140-220 aa) (STJ191711) | Login | Anti-MAGEB18 antibody (140-220 aa) (STJ191711) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGED1 antibody (200-280 aa) (STJ191712) | Login | Anti-MAGED1 antibody (200-280 aa) (STJ191712) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGED2 antibody (120-200 aa) (STJ191713) | Login | Anti-MAGED2 antibody (120-200 aa) (STJ191713) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGED4/MAGED4B antibody (300-380 aa) (STJ191714) | Login | Anti-MAGED4/MAGED4B antibody (300-380 aa) (STJ191714) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGEE2 antibody (240-320 aa) (STJ191715) | Login | Anti-MAGEE2 antibody (240-320 aa) (STJ191715) | ||||||||||||||||
|
||||||||||||||||||
Anti-NSMCE3 antibody (110-190 aa) (STJ191716) | Login | Anti-NSMCE3 antibody (110-190 aa) (STJ191716) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGEH1 antibody (10-90 aa) (STJ191717) | Login | Anti-MAGEH1 antibody (10-90 aa) (STJ191717) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAPK12 antibody (70-150 aa) (STJ191718) | Login | Anti-MAPK12 antibody (70-150 aa) (STJ191718) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAPK13 antibody (200-280 aa) (STJ191719) | Login | Anti-MAPK13 antibody (200-280 aa) (STJ191719) | ||||||||||||||||
|
||||||||||||||||||
Anti-LAMTOR3 antibody (30-110 aa) (STJ191720) | Login | Anti-LAMTOR3 antibody (30-110 aa) (STJ191720) | ||||||||||||||||
|
||||||||||||||||||
Anti-AKAP4 antibody (430-510 aa) (STJ191736) | Login | Anti-AKAP4 antibody (430-510 aa) (STJ191736) | ||||||||||||||||
|
||||||||||||||||||
Anti-RIOX2 antibody (STJ191782) | Login | Anti-RIOX2 antibody (STJ191782) | ||||||||||||||||
|
||||||||||||||||||
Anti-ALKBH3 antibody (110-190 aa) (STJ191787) | Login | Anti-ALKBH3 antibody (110-190 aa) (STJ191787) | ||||||||||||||||
|
||||||||||||||||||
Anti-SLC49A4 antibody (170-250 aa) (STJ191791) | Login | Anti-SLC49A4 antibody (170-250 aa) (STJ191791) | ||||||||||||||||
|
||||||||||||||||||
Anti-HNRNPAB antibody (STJ191793) | Login | Anti-HNRNPAB antibody (STJ191793) | ||||||||||||||||
|
||||||||||||||||||
Anti-EBNA1BP2 antibody (140-220 aa) (STJ191794) | Login | Anti-EBNA1BP2 antibody (140-220 aa) (STJ191794) | ||||||||||||||||
|
||||||||||||||||||
Anti-ING2 antibody (STJ191949) | Login | Anti-ING2 antibody (STJ191949) | ||||||||||||||||
|
||||||||||||||||||
Anti-BACH2 antibody (250-330 aa) (STJ191801) | Login | Anti-BACH2 antibody (250-330 aa) (STJ191801) | ||||||||||||||||
|